PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16242136

Facilitated column selection in pharmaceutical analyses using a simple column classification system.

Dóra Visky·Erik Haghedooren·Pieter Dehouck·Zsuzsanna Kovács·Kristof Kóczián·Béla Noszál·Jos Hoogmartens·Erwin Adams
View original source ↗Export metadata ↓

Abstract

In this paper, the performance of a previously developed classification system applied to pharmaceutical chromatographic analyses, is investigated. The separation of seven different drug substances from their respective impurities was studied. The chromatographic procedure for acetylsalicylic acid, clindamycin hydrochloride, buflomedil hydrochloride, chloramphenicol sodium succinate, nimesulide and phenoxymethylpenicillin was performed according to the corresponding European Pharmacopoeia (Ph. Eur.) monograph. The separation of dihydrostreptomycin sulphate was performed according to the literature. It is shown that the column ranking system is a helpful tool in the selection of a suitable column in these analyses.

Explore related subjects

AspirinChloramphenicolChromatography, LiquidClindamycinDihydrostreptomycin SulfatePenicillin VPharmaceutical PreparationsPyrrolidinesSensitivity and SpecificitySulfonamidesJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dóra Visky, Erik Haghedooren, Pieter Dehouck, Zsuzsanna Kovács, Kristof Kóczián, Béla Noszál, Jos Hoogmartens, Erwin Adams. 2005-10-19. Facilitated column selection in pharmaceutical analyses using a simple column classification system.. https://doi.org/10.1016/j.chroma.2005.09.069

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Dual antithrombotic therapy after implantation of coronary stents].

Dual antiplatelet-aggregation treatment with aspirin and clopidogrel after coronary stent implantation is nowadays standard peri-interventional practice, although its use is not yet licensed for this indication in many European countries. Clopidogrel administration is initiated before PCI with a loading dose of 300 mg when given at least 6 hours before PCI, otherwise 600 mg. The required duration of combined (aspirin + clopidogrel) antiplatelet-aggregation treatment after coronary stent implantation depends on the type of stent and the pre-existing disease. After bare-metal stent implantation dual antiplatelet medication is needed for at least 3-4 weeks, after drug-eluting stent implantation 6 months, after coronary brachytherapy 12 months, and 9 months after an acute coronary syndrome. These time intervals should also be respected before any elective surgical intervention. Early operations, because postponement is impossible, should be performed under antiplatelet-aggregation treatment after assessment of bleeding risk in the individual case. Premature termination of this treatment carries an increased risk of serious cardiovascular events, especially stent thrombosis and myocardial infarction. Prolonged antiplatelet-aggregation treatment is of benefit especially in patients with a high risk of serious cardiovascular events. Patients with an indication for long-term anticoagulation may require, during the period of highest risk of stent thrombosis after stent implantation, administration of combined aspirin, clopidogrel and anticoagulants with an INR target value in the lower therapeutic range. The increased risk of bleeding must be weighed up against the potential benefit.

Aspirin↗